Cell line · CVCL_4633
Papers37
1 to 20 of 37
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| UV irradiation drives lineage-specific MITF-mediated transcription of PD-L1 to confer immune tolerance to UV-mutated melanocytes. | Immunity | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Metabolic buffering restricts phenotype switching in melanoma. | EMBO J | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Extracellular matrix stiffness determines the phenotypic behavior of dedifferentiated melanoma cells through a DDR1/2-dependent YAP mechanotransduction pathway. | Oncogenesis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| AhR-dependent ferroptosis as a therapeutic opportunity to counteract BRAFi-resistance in melanoma. | Cell Death Discov | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Microbial Chemical Diversity and Cytotoxic Potential From Brazilian Ferruginous Caves: A Pioneering Metabolomic Survey. | Chem Biodivers | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The novel amino-artemisinin derivative WHN-11 disrupts mitochondria and protein homeostasis, and induces autophagy and apoptosis in cancer cells. | Sci Rep | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Uncovering Novel lncRNAs Linked to Melanoma Growth and Migration with CRISPR Inhibition Screening. | Cancer Res Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Rotenoids from the Roots of Vicia faba L. (Fabaceae): Structural Characterization, Cytotoxic Effects, and Molecular Docking. | Chem Biodivers | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Fatty acid uptake activates an AXL-CAV1-β-catenin axis to drive melanoma progression. | Genes Dev | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Pan-inhibition of super-enhancer-driven oncogenic transcription by next-generation synthetic ecteinascidins yields potent anti-cancer activity. | Nat Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Splicing control by PHF5A is crucial for melanoma cell survival. | Cell Prolif | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Long non-coding RNA GRASLND links melanoma differentiation and interferon-gamma response. | Front Mol Biosci | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints. | Oncogene | 2024 | Its Methods give the RRID and name the line | PubMed | |
| PubMed 37425776 | bioRxiv | 2023 | Its Methods give the RRID and name the line | PubMed | |
| KRAS and NRAS Translation Is Increased upon MEK Inhibitors-Induced Processing Bodies Dissolution. | Cancers (Basel) | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Scaffold coupling: ERK activation by trans-phosphorylation across different scaffold protein species. | Sci Adv | 2023 | Its Methods give the RRID and name the line | PubMed | |
| MAGOH and MAGOHB Knockdown in Melanoma Cells Decreases Nonsense-Mediated Decay Activity and Promotes Apoptosis via Upregulation of GADD45A. | Cells | 2022 | Its Methods give the RRID and name the line | PubMed | |
| MOSPD2 is an endoplasmic reticulum-lipid droplet tether functioning in LD homeostasis. | J Cell Biol | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Altered BAF occupancy and transcription factor dynamics in PBAF-deficient melanoma. | Cell Rep | 2022 | Its Methods give the RRID and name the line | PubMed | |
| BRAFV600E induces reversible mitotic arrest in human melanocytes via microrna-mediated suppression of AURKB. | Elife | 2021 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_4633/papers